Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Moodys
Boehringer Ingelheim
Dow
Medtronic

Last Updated: October 7, 2022

Litigation Details for VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. SOLARIS PHARMA CORP. (D.N.J. 2018)


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. SOLARIS PHARMA CORP. (D.N.J. 2018)

Docket See Plans and Pricing Date Filed 2018-09-07
Court District Court, D. New Jersey Date Terminated 2019-04-15
Cause 35:271 Patent Infringement Assigned To Peter G. Sheridan
Jury Demand None Referred To Lois H. Goodman
Parties DOW PHARMACEUTICAL SCIENCES, INC.
Patents 7,214,506; 8,039,494; 8,486,978; 9,302,009; 9,566,272; 9,662,394; 9,861,698; 9,877,955
Attorneys JUSTIN JAMES HASFORD
Firms Winston and Strawn LLP
Link to Docket External link to docket
Small Molecule Drugs cited in VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. SOLARIS PHARMA CORP.
The small molecule drug covered by the patents cited in this case is See Plans and Pricing .

Details for VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. SOLARIS PHARMA CORP. (D.N.J. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-09-07 1 United States Patent Nos. 7,214,506 (“the ’506 patent”), 8,039,494 (“the ’494 patent”), 8,486,978 (“…506 patent, the ’494 patent, the ’978 patent, the ’009 patent, the ’272 patent, the ’394 patent, the …’494 patent, the ’978 patent, the ’009 patent, the ’272 patent, the ’394 patent, the ’698 patent, and…’506 patent, the ’494 patent, the ’978 patent, the ’009 patent, the ’272 patent, the ’394 patent, the…506 patent, the ’494 patent, the ’978 patent, the ’009 patent, the ’272 patent, the ’394 patent, the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Express Scripts
AstraZeneca
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.